IBM enters the final week of August with a daily chart that is improving but not yet repaired. The stock closed the latest completed session at $235.68, holding above its 20-day simple moving average near $231.70 after rebounding 18.3% from the July low at $199.19. That recovery has restored short-term momentum, yet price remains below the 50-day and 100-day averages clustered around $247–$248 and almost 29% beneath the June record at $332.46. The immediate decision is therefore unusually clear: buyers need to defend the $232–$233 area and convert $241.80 into support, while sellers need a close back below the 20-day average to show that the post-gap rebound has failed.

🧭 IBM Technical Analysis at a Glance

The latest completed daily candle opened at $233.71, traded between $233.12 and $238.72, and closed at $235.68 on 3.89 million shares. The 0.85% gain followed a close at $233.69 and left IBM near the upper half of its recent 20-day range, which extends from $215.11 to $241.80. The candle was constructive because buyers absorbed early weakness and closed near the upper part of the session, but volume was below the 20-day average of roughly 6.67 million shares. It improved the chart without producing the participation normally associated with a decisive breakout.

The short-term trend is positive: IBM has gained about 14.0% over the latest 20 completed sessions and is trading above its 20-day average. The intermediate trend is still damaged because price remains below the 50-day average at $247.36 and the 100-day average at $247.64. The long-term trend is also under pressure, with the 200-day average near $266.00 declining into the recovery zone. This mixed alignment is the defining feature of the chart. Short-term buyers are in control of the rebound, but they have not yet displaced the supply created by July’s downside gap.

🕳️ The July Gap Still Controls the Structure

IBM’s current chart cannot be understood without the discontinuity between July 13 and July 14. The stock closed July 13 at $290.23 and opened the next session at $226.37, a downside opening gap of roughly 22%. It then traded as low as $213.22 and closed at $217.07 on extraordinary volume. That event reset the market’s reference points. Holders who owned the stock above $260 suddenly faced a large unrealized loss, while new buyers received a much lower cost basis. The result is a broad overhead supply zone that the August rebound must work through in stages.

Gap damage often creates two different technical clocks. The fast clock measures the oversold rebound from the panic low. On that clock, IBM has performed well: the stock advanced from $199.19 to $241.80 and reclaimed the 20-day moving average. The slower clock measures whether price can rebuild acceptance beneath and eventually inside the gap. On that clock, the chart is still incomplete. The rebound has not reached the $247–$248 moving-average cluster, much less the lower edge of the pre-gap trading region. Traders should therefore avoid treating a strong August bounce as proof that the July regime has been reversed.

The fundamental catalyst behind the gap remains relevant because it helps explain why resistance may be persistent. On July 22, IBM reported second-quarter results, while Reuters reported that the company cut its annual revenue-growth forecast as customers prioritized artificial-intelligence infrastructure spending. A chart does not need to relitigate the earnings report every day, but it does need to respect the inventory created by the repricing. Each rally toward the gap encounters investors deciding whether to exit, reduce exposure or wait for fuller recovery.

📈 The 20-Day Average Has Become the First Trend Test

The 20-day simple moving average near $231.70 is the most important short-term reference. IBM spent much of the post-gap period below that line, then reclaimed it as the August rebound accelerated. A rising short average beneath price indicates that recent closing values are improving faster than the older observations rolling out of the calculation. It is not a guarantee of continuation, but it marks the boundary between an active recovery and a return to weak mean reversion.

The quality of a support test matters more than the first touch. A brief intraday move below $232 followed by a close above $233 would show that sellers found liquidity but could not establish lower value. A daily close below $231.70, followed by a failed recovery into $232–$234, would be materially different. That sequence would turn the moving average from support into resistance and expose the August base near $224–$226. Because IBM’s 14-day average true range is about $6.54, traders should expect ordinary daily noise around the average. Confirmation requires closes and follow-through, not a few cents of penetration.

The 20-day average is also rising toward price, which reduces the distance required for a healthy retest. A stock that must fall 15% to reach its short-term trend reference is extended even when the trend is strong. IBM now sits less than two percent above its 20-day average. That proximity means buyers can prove demand without accepting a large drawdown. It also means the market has little room for complacency: a weak session can quickly shift the chart from constructive consolidation to a failed recovery.

🧱 $241.80 Is the First Breakout Barrier

The August 11 high at $241.80 is the first resistance that must fall. It is the highest completed-session print of the latest 20-day window and the level where the rebound first met meaningful supply. Price does not need to break it immediately to preserve the recovery, but repeated failures beneath it would create a visible ceiling. The longer IBM trades under $241.80 while momentum cools, the more likely short-term buyers are to protect gains rather than add exposure.

A valid breakout should include a daily close above $241.80, preferably with volume above the recent average, followed by a retest that holds roughly $239–$242. That would demonstrate acceptance rather than a temporary liquidity sweep. The first objective would then be the $247.36–$247.64 cluster formed by the 50-day and 100-day averages. Because two widely watched averages sit within less than 30 cents of each other, the region is likely to attract both systematic selling and discretionary profit-taking. A move through $241.80 opens the door; acceptance above $248 changes the intermediate structure.

An intraday spike above $241.80 that closes back below $239 would be less constructive. It would show that buyers could reach the prior high but could not maintain value beyond it. The most bearish version would pair that failed breakout with high volume and a subsequent close below the 20-day average. That sequence would trap late buyers and convert the August range into a distribution pattern. Until then, $241.80 should be treated as a decision point rather than an automatic short signal.

🏗️ The $247–$248 Cluster Separates a Bounce from a Repair

IBM’s 50-day average near $247.36 and 100-day average near $247.64 are almost perfectly aligned. This convergence is technically significant because it compresses two different horizons into one resistance band. Shorter-horizon participants see the average price of approximately ten trading weeks; medium-horizon participants see about five months of closing history. When both references overlap after a sharp gap, the band can become a concentrated inventory zone.

The stock can still rally into this region while remaining in a damaged intermediate trend. The stronger signal would be a close above $248 followed by several sessions holding the level as support. That would place price above the 20-day, 50-day and 100-day averages and begin to restore a bullish stack. The next resistance would then appear near $255–$260, an area that captures post-gap reaction highs and psychological round-number supply. Above that, the declining 200-day average near $266 would become the major regime test.

Failure at $247–$248 would not automatically end the rebound. A controlled pullback that holds $232 could create a higher low and allow the 20-day average to rise beneath price. The problem begins if rejection from the moving-average cluster is followed by acceptance below $224. That would indicate that the recovery distributed stock into resistance without changing the broader trend. The distinction between a pause and a failure therefore depends on what happens after resistance, not merely on whether the first attempt succeeds.

⚙️ Momentum Is Positive but No Longer Explosive

The 14-day relative strength index is approximately 60.5. That reading is above the neutral 50 line but below conventional overbought territory. It confirms that average gains have outweighed average losses during the rebound without indicating the kind of extreme momentum that often precedes immediate exhaustion. For bulls, this is constructive: IBM has room to test resistance without first requiring a deep oscillator reset. For bears, it means a short position based only on “overbought” conditions lacks evidence.

The 12-session rate of change is approximately -0.1%, which appears weak beside the 20-day price gain. The difference reveals the shape of the rebound. Much of IBM’s advance occurred before the latest 12-session window, while recent price action has become more rotational beneath $241.80. Momentum has improved from the July collapse, but the fastest phase is no longer accelerating. That makes the next range break more informative. A close above $241.80 would re-expand momentum; a close below the 20-day average would confirm that the rebound has lost speed.

Stochastic RSI is near 29, placing the short momentum cycle in the lower half of its recent range even though the conventional RSI remains positive. This combination can be constructive when price holds support: the broader recovery stays intact while the fast oscillator resets, creating room for another push. It becomes bearish if the oscillator turns down from a weak level while price loses $231–$232. Indicators should be read as a sequence. Momentum compression above support can launch a breakout; momentum compression beneath resistance can also precede a breakdown.

🔊 Volume Has Not Confirmed a New Regime

The latest completed session traded about 3.89 million shares, well below the 20-day average near 6.67 million. The quiet gain suggests that sellers were not aggressive, but it also means buyers did not demonstrate broad conviction. In a recovery following a high-volume gap, volume should be interpreted asymmetrically. Light volume during consolidation can be healthy because supply is drying up. Light volume on a breakout attempt is less persuasive because the market needs fresh demand to absorb trapped inventory.

The July gap session established an unusually high participation benchmark, so no ordinary August session should be expected to match it. The more useful comparison is the recent average and the behavior at specific levels. A close above $241.80 on more than 6.7 million shares would materially strengthen the breakout. A low-volume drift above resistance could still work, but it would require a successful retest. Conversely, a break below $231.70 on expanding volume would show that sellers are becoming active at the exact point where the recovery should attract demand.

Volume also helps distinguish institutional accumulation from short covering. A rebound driven primarily by investors closing bearish positions can move quickly but lose energy after obvious resistance is reached. Sustained accumulation tends to produce repeated high-volume advances, contained pullbacks and higher lows. IBM’s chart currently shows enough demand to support a recovery, but not yet enough evidence to declare a durable institutional change. The burden of proof belongs to the next breakout and retest.

📏 Volatility Demands Structural Stops

IBM’s 14-day average true range near $6.54 is roughly 2.8% of the latest close. That volatility makes narrow intraday invalidation unreliable. A move from $235.68 to $232 is less than one ATR and can occur during a normal session without changing the daily structure. Traders who place stops only a few cents below a round number risk being removed by ordinary noise. The alternative is not to accept unlimited loss; it is to size positions so that a wider, structurally meaningful stop remains tolerable.

The ATR also clarifies target distance. A move from $235.68 to $241.80 is about 0.94 ATR, so a resistance retest is plausible within one strong session. Reaching the $247.50 moving-average cluster requires roughly 1.8 ATR, while a return to $266 is more than 4.6 ATR away. Those distances do not predict timing, but they prevent distant targets from being confused with immediate ones. The chart must earn each stage: $241.80 first, $247–$248 second, $255–$260 third, and the 200-day average only after intermediate repair.

On the downside, $224–$226 is about 1.5 to 1.8 ATR below the latest close, while $215.11 is more than three ATR away. A direct move to the July low would require a much larger shift in volatility and market sentiment. That is why the bearish scenario begins with failed support and failed retests rather than an instant collapse forecast. Price usually reveals regime change in steps.

🌐 Broader Market Context Can Amplify the Break

IBM’s chart is stock-specific, but its next move will not occur in isolation. On August 24, Reuters reported pressure in S&P 500 and Nasdaq futures as investors waited for major technology earnings and assessed geopolitical developments. A risk-off technology session can make it harder for IBM to break overhead resistance, while a broad rotation into mature cash-generative technology companies could help the stock outperform even if high-growth names weaken.

The company also announced an artificial-intelligence infrastructure agreement earlier in August. IBM said it signed a multi-year agreement with Together AI, and Reuters valued the deal at $240 million. The news helps explain why attention returned to the stock during the rebound, but it does not erase the earnings gap. Positive catalysts matter most when price confirms that investors are willing to pay higher levels after the headline fades.

Cross-market confirmation should focus on relative behavior. If major technology indices remain weak while IBM closes above $241.80 on expanding volume, the stock would be demonstrating independent demand. If the entire sector rallies and IBM still fails beneath the first resistance, the relative weakness would be a warning. Technical analysis becomes more informative when the asset’s response is compared with the opportunity the broader tape provides.

🟢 Bullish Scenario: Defend $232 and Clear $248

The bullish scenario begins with IBM holding $231.70–$233.00 on completed daily closes. A constructive test could briefly trade below the 20-day average, recover during the session and close above $234. The next confirmation is a close above $241.80 with better participation. That would complete a short-term higher-high sequence and open the $247–$248 moving-average cluster.

The stronger bullish case requires acceptance above $248. A successful retest of that band would indicate that the August rebound has progressed from oversold recovery to intermediate repair. The first objectives would become $255–$260, followed by the 200-day average near $266. A close above $266 would not immediately fill the July gap, but it would restore a much healthier moving-average structure and reduce the probability that every rally is merely an opportunity for trapped holders to exit.

The bullish scenario weakens below $231.70 and is invalidated for the short term by acceptance below $224. A move beneath $224 would break the higher-low sequence and expose $215.11. The larger recovery thesis remains possible above $199.19, but the burden of proof would return to buyers. A valid bullish plan therefore defines both the trigger and the level that proves it wrong.

🟡 Neutral Scenario: Build Value Between $224 and $242

The neutral scenario is a multi-session range between $224–$226 support and $241.80 resistance. This outcome would allow the 20-day average to rise, the 50-day average to decline toward price and the fast momentum cycle to reset. It could feel frustrating after a rapid rebound, but consolidation above the July base would be technically healthier than a vertical attempt to fill the gap.

Inside that range, the midpoint around $233 offers limited directional advantage. The better information appears at the boundaries. A dip into $224–$226 that produces a strong reversal would confirm demand. A rally into $241.80 that closes near the high would show that supply is being absorbed. Low volume in the center and expanding volume at successful tests would improve the base. Repeated high-volume rejections at the top or closes near the bottom would weaken it.

The neutral case ends with acceptance outside the range. Above $241.80, the moving-average cluster becomes active. Below $224, the chart shifts toward a deeper retracement. Until one side proves control, traders should resist turning every intraday move into a new trend. A range is not indecision without value; it is the market’s process for transferring inventory after a shock.

🔴 Bearish Scenario: Lose the 20-Day Average and Fail the Retest

The bearish scenario becomes credible if IBM closes below $231.70 and then fails to reclaim $232–$234. The first downside objective would be $224–$226, where the recovery previously built support. A close below $224 would expose the 20-day range low at $215.11. Because the July gap created abnormal volatility, the move could accelerate if short-term buyers all use similar invalidation levels.

A break below $215.11 would return attention to $205 and the July low at $199.19. Acceptance below $199 would create a fresh lower low and signal that the market is repricing the stock beyond the original gap reaction. The bearish case does not require IBM to revisit the entire decline immediately. Its first job is simply to show that the 20-day average no longer attracts demand.

The immediate bearish scenario is invalidated by a recovery above $241.80. The broader bearish thesis weakens materially above $248 and becomes difficult to defend if IBM holds above the 200-day average. Traders should not short solely because price remains below old highs; they need evidence that current support has turned into resistance.

🎓 Educational Long Frameworks

An educational pullback framework can wait for IBM to test $231.70–$233, recover during the session and close above a clearly defined reversal high. Invalidation belongs below the confirmed swing low rather than at an arbitrary percentage. The first objective is $241.80, where partial risk reduction may be appropriate because resistance is proven. A second objective becomes active only after a close above $241.80.

An educational breakout framework can wait for a daily close above $241.80 and a retest that holds $239–$242. This approach sacrifices a lower entry in exchange for evidence that supply has been absorbed. The first target is the $247–$248 cluster. If price closes above that band and holds it, $255–$260 becomes the next zone. Position size should reflect the $6.54 ATR and the distance to structural invalidation.

Both frameworks should account for the gap. A trade based on short-term recovery should not quietly become a long-term investment if $224 fails. The trader must decide in advance whether the thesis is a bounce, a moving-average reclaim or a full intermediate repair. Each thesis has a different trigger, target and invalidation.

🎓 Educational Short Frameworks

An educational breakdown framework requires a close below $231.70 followed by a failed retest from underneath. The first objective is $224–$226, followed by $215.11. A trader entering before the failed retest accepts more uncertainty because a simple intraday move below the average can reverse. Waiting for resistance confirmation reduces false signals but may produce a less favorable price.

An educational rejection framework can become relevant near $247–$248 only after price prints a failed breakout and closes back below $241.80. The invalidation belongs above the rejection high. Shorting the first touch of the moving averages without reversal evidence is risky because a powerful recovery can move through concentrated resistance quickly once sellers are absorbed.

These scenarios are analytical frameworks rather than recommendations. A sound process defines what must happen before entry, what price action disproves the idea and how much capital can be lost if the thesis fails. The goal is not to predict every candle; it is to respond consistently when evidence changes.

🧠 Block2Learn Base Case

The base case is a constructive consolidation above the 20-day average followed by another test of $241.80. IBM’s close above $235, RSI near 60 and positive 20-day return favor the rebound. The weak 12-session rate of change, below-average latest volume and heavy $247–$248 resistance favor patience. These signals are compatible: the short trend is improving, but the intermediate trend has not yet repaired.

The base case strengthens with a close above $241.80 and becomes bullish above $248. It weakens below $231.70 and shifts bearish below $224. A direct move above $248 without high volume could still succeed, but it would need a clean retest. A direct move below $224 would signal that the market did not use the August pause to build durable value.

Independent market context supports the calibration. TradingView’s IBM page identified the NYSE listing and showed the stock near $234.10 during the August 24 session, about 0.7% below the latest certified close used for this analysis. That difference reflects session timing rather than a contradiction. The methodology uses completed daily candles through August 21; the live quote is context, not a substitute for the closed series.

🚨 Confirmation and Invalidation Map

For the immediate bullish case, confirmation is a daily close above $241.80. Full intermediate confirmation is acceptance above $247–$248, ideally with a successful retest. The immediate bullish case is invalidated below $231.70, while the broader recovery is invalidated by acceptance below $224. The July base faces serious risk below $215.11, and the entire post-gap recovery fails beneath $199.19.

For the bearish case, confirmation is a close below $231.70 followed by a failed reclaim. Continuation confirmation is a close below $224. The immediate bearish case is invalidated above $241.80, and the intermediate bearish thesis weakens above $248. A close above the 200-day average near $266 would force a full reassessment.

Candle state is essential. The certified levels in this analysis come from completed NYSE daily sessions through August 21. The August 24 candle can trade beyond support or resistance without confirming the move. A wick shows where liquidity was tested; the close shows where the market accepted value; follow-through shows whether that acceptance persisted. Sequences are more reliable than alerts.

🎯 Final IBM Technical Analysis Outlook

IBM has recovered enough to put buyers back in control of the short-term chart, but not enough to erase the July gap. The stock closed at $235.68 above the 20-day average near $231.70, with RSI near 60 and a 20-day gain of about 14%. The rebound remains below the 50-day and 100-day averages near $247–$248, while the 200-day average near $266 defines the larger regime test. Support is concentrated at $231.70–$233 and $224–$226. Resistance is concentrated at $241.80, $247–$248 and $255–$260.

The disciplined conclusion is conditional. Holding $232 and breaking $241.80 would keep the recovery active. Holding above $248 would transform the move into an intermediate repair and expose $255–$260. Losing the 20-day average would warn that momentum is fading; losing $224 would shift the chart toward $215.11 and possibly the July low. IBM does not need to fill the gap immediately to remain constructive, but it must prove that buyers can defend the new value area when the first serious support test arrives.

Learning Path

Readers who want to develop a repeatable framework for trend, support, resistance, momentum, volatility and position sizing can continue through the Block2Learn Learning Path and the site’s broader Chart Analysis archive. The objective is to replace prediction with conditional planning: define the evidence, map the invalidation and adapt when completed candles change the structure.

⚠️ Disclaimer

This analysis is provided exclusively for educational and informational purposes. It does not constitute financial advice, investment advice or a recommendation to buy or sell IBM or any other financial instrument. Equity markets involve substantial risk, and gap-driven volatility can produce rapid losses. Every trader and investor should conduct independent research, evaluate personal risk tolerance and use appropriate risk-management strategies before making any financial decision.